The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection. Starvaggi J, Previti S, Zappala M, Ettari R, et al. Int J Mol Sci 2024;25:4376.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Starvaggi J, Previti S, Zappala M, Ettari R, et al. The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection. Int J Mol Sci 2024;25:4376.
PMID: 38673962